{"id":588,"date":"2013-03-02T19:05:33","date_gmt":"2013-03-02T10:05:33","guid":{"rendered":"http:\/\/singularities.sfc.keio.ac.jp\/wp\/?page_id=588"},"modified":"2014-04-10T11:41:08","modified_gmt":"2014-04-10T02:41:08","slug":"research-achievments","status":"publish","type":"page","link":"https:\/\/singularities.sfc.keio.ac.jp\/wp\/?page_id=588","title":{"rendered":"Research Achievments"},"content":{"rendered":"

Publications<\/h1>\n
    \n
  1. \u201cSurvival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multi center retrospective observational study (JBCRG-C03 study).\u201d Takada M, Ishiguro H, Nagai S, Ohtani S, Kawabata H, Yanagita Y, Hozumi Y, Shimizu C, Takao S, Sato N, Kosaka Y, Sagara Y, Iwata H, Ohno S, Kuroi K, Masuda N, Yamashiro H, Sugimoto M, Kondo M, Naito Y, Sasano H, Inamoto T, Morita S, Toi M. Breast Cancer Res Treat<\/i> 2014 Mar 30. [Epub ahead of print] Journal Site<\/a><\/span><\/li>\n
  2. “Contribution of quantitative changes in individual ionic current systems to the embryonic development of ventricular myocytes: a simulation study.” Okubo C, Sano HI, Naito Y, Tomita M. J Physiol Sci.<\/i> 63<\/b>(5):355-67 (2013)\u00a0Open Access<\/a><\/span>\u00a0PDF<\/a><\/span><\/li>\n
  3. \u201cPredictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique.\u201d Takada M, Sugimoto M, Ohno S, Kuroi K, Sato N, Bando H, Masuda N, Iwata H, Kondo M, Sasano H, Chow LW, Inamoto T, Naito Y, Tomita M, Toi M. Breast Cancer Res Treat<\/i> 134<\/b>:661-70 (2012) Journal Site<\/a><\/span><\/li>\n
  4. \u201cPrediction of axillary lymph node metastasis in primary breast cancer patients using a decision tree-based model\u201d Takada M, Sugimoto M, Naito Y, Moon HG, Han W, Noh DY, Kondo M, Kuroi K, Sasano H, Inamoto T, Tomita M, Toi M. BMC Med Inform Decis Mak<\/i> 12<\/b>:54\u00a0(2012) Open Access<\/a><\/span> PDF<\/a><\/span><\/li>\n
  5. \u201cComputational assessment of insulin secretion and insulin sensitivity from 2-h oral glucose tolerance tests for clinical use for type 2 diabetes\u201d Seike M, Saitou T, Kouchi Y, Ohara T, Matsuhisa M, Sakaguchi K, Tomita K, Kosugi K, Kashiwagi A, Kasuga M, Tomita M, Naito Y, Nakajima H.\u00a0 J Physiol Sci<\/i>. 61<\/b>(4):321-30. (2011) Open Access<\/a><\/span> PDF<\/a><\/span><\/li>\n
  6. \u201cPredictive value of CD24 and CD44 for neoadjuvant chemotherapy response and prognosis in primary breast cancer patients\u201d Horiguchi K, Toi M, Horiguchi S, Sugimoto M, Naito Y, Hayashi Y, Ueno T, Ohno S, Funata N, Kuroi K, Tomita M, Eishi1 YJ. Med. Dent. Sci<\/i>. 57<\/b>:165-175 (2010) PDF<\/a><\/span><\/li>\n
  7. \u201cConstruction of a biological tissue model based on a single-cell model: a computer simulation of metabolic heterogeneity in the liver lobule\u201d Ohno H, Naito Y, Nakajima H, Tomita M. Artif Life<\/i>. 14<\/b>(1):3-28. (2008) Open Access<\/a><\/span> PDF<\/a><\/span> Summary<\/a><\/span><\/li>\n
  8. \u201cSimulation of developmental changes in action potential with ventricular cell models\u201d Itoh H, Naito Y, Tomita M., Syst Synth Biol<\/i>. 1<\/b>(1):11-23. (2007) Open Access<\/a><\/span> PDF<\/a><\/span><\/li>\n
  9. \u201cA trial of somatic gene targeting in vivo with an adenovirus vector.\u201d Ino A, Naito Y, Mizuguchi H, Handa N, Hayakawa T, Kobayashi I., Genet Vaccines<\/i> Ther. 3<\/b>:8. (2005) Open Access<\/a><\/span> PDF<\/a><\/span><\/li>\n
  10. \u201cE-CELL 2: Multi-platform E-CELL simulation system\u201d Takahashi K, Ishikawa N, Sadamoto Y, Sasamoto H, Ohta S, Shiozawa A, Miyoshi F, Naito Y, Nakayama Y, Tomita M., Bioinformatics<\/i>. 19<\/b>(13): 1727-1729. (2003) Open Access<\/a><\/span> PDF<\/a><\/span><\/li>\n
  11. \u201cA DNA methyltransferase can protect the genome from postdisturbance attack by a restriction-modification gene complex\u201d Takahashi N, Naito Y, Handa N, Kobayashi I., J Bacteriol<\/i>. 184<\/b>(22):6100-8. (2002) Open Access<\/a><\/span> PDF<\/a><\/span><\/li>\n
  12. \u201cEvolution of sequence recognition by restriction-modification enzymes: selective pressure for specificitydecrease\u201d Chinen A, Naito Y, Handa N, Kobayashi I., Mol Biol Evol<\/i>. 17<\/b>(11):1610-9. (2000) Open Access<\/a><\/span> PDF<\/a><\/span><\/li>\n
  13. \u201cMutation correction by homologous recombination with an adenovirus vector\u201d Fujita-Kusano A, Naito Y, Saito I, Kobayashi I., Methods Mol Biol<\/i>. 133<\/b>:101-9. (2000) Journal Site<\/a><\/span><\/li>\n
  14. \u201cSelfish restriction modification genes: resistanceof a resident R\/M plasmid to displacement by an incompatible plasmid mediatedby host killing\u201d Naito Y, Naito T, Kobayashi I., Biol Chem<\/i>. 379<\/b>(4-5):429-36. (1998) Journal Site<\/a><\/span><\/li>\n
  15. \u201cGenetic diagnosis by polymerase chain reaction and electrospray ionization mass spectrometry: detection of five base deletion from blood DNA of a familial adenomatous polyposis patient\u201d Naito, Y., Ishikawa, K., Koga, Y., Tsuneyoshi, T., Terunuma, H., Arakawa, R., J. Am. Soc. Mass Spectrom<\/i> 8<\/b>:737-742. (1997) Journal Site<\/a><\/span><\/li>\n
  16. \u201cMass spectrometric gene diagnosis of one-base substitution from polymerase chain reaction amplified human DNA\u201d Tsuneyoshi T, Ishikawa K, Koga Y, Naito Y, Baba S, Terunuma H, Arakawa R,Prockop DJ., Rapid Commun Mass Spectrom<\/i>.11<\/b>(7):719-22. (1997) Journal Site<\/a><\/span><\/li>\n
  17. \u201cMolecular mass measurement of polymerase chain reaction products amplified from human blood DNA by electrospray ionization mass spectrometry\u201d Naito Y, Ishikawa K, Koga Y, Tsuneyoshi T, Terunuma H, Arakawa R., Rapid Commun Mass Spectrom<\/i>.9<\/b>(15):1484-6. (1995) Journal Site<\/a><\/span><\/li>\n<\/ol>\n

    \u90a6\u6587\u539f\u8457\u8ad6\u6587<\/h1>\n
      \n
    1. \u7cd6\u5c3f\u75c5\u30e2\u30c7\u30eb\u306b\u3088\u308b\u75c5\u614b\u63a8\u5b9a, \u9ad8\u5730 \u6cf0\u6d69, \u6589\u85e4 \u592a\u8a08\u96c4, \u6e05\u5bb6 \u8056\u5609, \u6d45\u91ce \u85ab, \u5185\u85e4 \u6cf0\u5b8f, \u4e2d\u5cf6 \u5f18, \u96fb\u5b50\u60c5\u5831\u901a\u4fe1\u5b66\u4f1a\u6280\u8853\u7814\u7a76\u5831\u544a(ME\u3068\u30d0\u30a4\u30aa\u30b5\u30a4\u30d0\u30cd\u30c6\u30a3\u30c3\u30af\u30b9), 105(221):23-26 (2005.07)<\/li>\n<\/ol>\n

      \u90a6\u6587\u7dcf\u8aac<\/h1>\n
        \n
      1. \u751f\u547d\u3092\u8a08\u7b97\u3057\u3066\u7406\u89e3\u3059\u308b\uff0c\u5185\u85e4 \u6cf0\u5b8f\uff0cKEIO SFC Journal, 13(2):49-60 (2014.03) PDF<\/a><\/span><\/li>\n
      2. \u30c7\u30fc\u30bf\u99c6\u52d5\u306e\u4e73\u304c\u3093\u8a3a\u65ad\u652f\u63f4\u30fb\u75c5\u614b\u4e88\u6e2c\uff0c\u5185\u85e4 \u6cf0\u5b8f\uff0c\u304c\u3093\u5206\u5b50\u6a19\u7684\u6cbb\u7642, 8(2):143-148 (2010.04)<\/li>\n
      3. \u7d30\u80de\u30fb\u7d44\u7e54\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u73fe\u72b6\u3000\u85ac\u52b9\u30fb\u6bd2\u6027\u306e\u4e88\u6e2c\u306b\u3080\u3051\u3066, \u5185\u85e4 \u6cf0\u5b8f, \u30d5\u30a1\u30eb\u30de\u30b7\u30a2, 44(9):885-889 (2008.09)<\/li>\n
      4. E-CELL\u30d7\u30ed\u30b8\u30a7\u30af\u30c8, \u5185\u85e4 \u6cf0\u5b8f, MEDICAL IMAGING TECHNOLOGY, 26(2):105-110 (2008.03)<\/li>\n
      5. \u30b7\u30b9\u30c6\u30e0\u30d0\u30a4\u30aa\u30ed\u30b8\u30fc\u306b\u3088\u308b\u7cd6\u5c3f\u75c5\u306e\u8a3a\u65ad\u89e3\u6790, \u4e2d\u5cf6 \u5f18, \u5185\u85e4 \u6cf0\u5b8f, \u9ad8\u5730 \u6cf0\u6d69, \u533b\u85ac\u30b8\u30e3\u30fc\u30ca\u30eb, 42(7):1860-1865 (2006.07)<\/li>\n
      6. \u7d30\u80de\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u306f\u4f55\u3092\u3082\u305f\u3089\u3059\u304b\uff1f, \u5185\u85e4 \u6cf0\u5b8f, \u5206\u5b50\u5fc3\u8840\u7ba1\u75c5, 4(5):470-476 (2003.10)<\/li>\n
      7. \u3088\u308a\u9ad8\u7cbe\u5ea6\u306a\u7d30\u80de\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u5b9f\u73fe\u306b\u5411\u3051\u3066, \u5185\u85e4 \u6cf0\u5b8f, \u51a8\u7530 \u52dd, \u6700\u65b0\u533b\u5b66, 58(6\u6708\u5897\u520a):1606-1616 (2003.06)<\/li>\n
      8. E-Cell\u3000\u7d30\u80de\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u53ef\u80fd\u6027, \u5185\u85e4 \u6cf0\u5b8f, \u51a8\u7530 \u52dd, \u8840\u7ba1\u533b\u5b66, 3(5):459-468 (2002.10)<\/li>\n
      9. \u7d30\u80de\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u3000E-CELL\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u306e\u6311\u6226, \u5185\u85e4 \u6cf0\u5b8f, \u51a8\u7530 \u52dd, BME, 16(1):36-42 (2002.01)<\/li>\n
      10. \u5236\u9650\u4fee\u98fe\u9175\u7d20\u306b\u3088\u308b\u30d7\u30ed\u30b0\u30e9\u30e0\u7d30\u80de\u6b7b, \u5185\u85e4 \u6cf0\u5b8f, \u5c0f\u6797 \u4e00\u4e09, Surgery Frontier, 3(3):268-270 (1996.09)<\/li>\n<\/ol>\n

        <\/p>\n

        \u56fd\u5185\u5b66\u4f1a\u767a\u8868<\/h1>\n
          \n
        1. \u30c7\u30fc\u30bf\u30de\u30a4\u30cb\u30f3\u30b0\u3092\u7528\u3044\u305f\u65b0\u3057\u3044\u8853\u524d\u5316\u5b66\u7642\u6cd5\u306e\u6cbb\u7642\u52b9\u679c\u4e88\u6e2c\u30e2\u30c7\u30eb\u306e\u958b\u767a\uff0c\u9ad8\u7530 \u6b63\u6cf0, \u6749\u672c \u660c\u5f18, \u5927\u91ce \u771f\u53f8, \u9ed2\u4e95 \u514b\u660c, \u4f50\u85e4 \u4fe1\u662d, \u5742\u6771 \u88d5\u5b50, \u5897\u7530 \u614e\u4e09, \u5ca9\u7530 \u5e83\u6cbb, \u8fd1\u85e4 \u6b63\u82f1, \u7b39\u91ce \u516c\u4f38, \u7a32\u672c \u4fca, \u5185\u85e4 \u6cf0\u5b8f, \u51a8\u7530 \u52dd, \u6238\u4e95 \u96c5\u548c\uff0c\u65e5\u672c\u4e73\u764c\u5b66\u4f1a\u7dcf\u4f1a\u30d7\u30ed\u30b0\u30e9\u30e0\u6284\u9332\u96c620\u56de Page303\uff082012.05\uff09<\/li>\n
        2. \u7cd6\u5c3f\u75c5\u30b7\u30df\u30e5\u30ec\u30fc\u30bf\u306b\u3088\u308b\u85ac\u5264\u594f\u529f\u7fa4\u4e88\u6e2c\uff0c\u6e05\u5bb6 \u8056\u5609, Wu Peihong, Liu Wei, Wang Lihua, Teng Xiangyu, \u9678 \u5efa\u9280, \u9ad8\u5730 \u6cf0\u6d69, \u5185\u85e4 \u6cf0\u5b8f, \u4e2d\u5cf6 \u5f18\uff0c\u7cd6\u5c3f\u75c5\uff080021-437X\uff0955\u5dfbSuppl.1 PageS-109\uff082012.04\uff09<\/li>\n
        3. \u5fc3\u7b4b\u7d30\u80de\u306e\u819c\u8208\u596e-\u53ce\u7e2e\u9023\u95a2\u306e\u305f\u3081\u306e\u30c7\u30b6\u30a4\u30f3\u30b9\u30da\u30fc\u30b9\u306e\u63a2\u7d22 \uff08Exploring the design space for excitation-contraction coupling of cardiomyocyte\uff09 \u5185\u85e4 \u6cf0\u5b8f, \u51a8\u7530 \u52dd\uff0c\u65e5\u672c\u751f\u5316\u5b66\u4f1a\u5927\u4f1a\u30fb\u65e5\u672c\u5206\u5b50\u751f\u7269\u5b66\u4f1a\u5e74\u4f1a\u5408\u540c\u5927\u4f1a\u8b1b\u6f14\u8981\u65e8\u96c683\u56de\u30fb33\u56de Page4P-1251\uff082010.12\uff09<\/li>\n
        4. \u7cd6\u5c3f\u75c5\u30b7\u30df\u30e5\u30ec\u30fc\u30bf\u306b\u3088\u308b\u85ac\u5264\u9069\u5408\u6027\u4e88\u6e2c\u3000\u30d3\u30b0\u30a2\u30ca\u30a4\u30c9\u85ac\u30fbSU\u85ac\uff0c\u6e05\u5bb6 \u8056\u5609, Wu Peihong, Liu Wei, Wang Lihua, Teng Xiangyu, \u9678 \u5efa\u9280, \u9ad8\u5730 \u6cf0\u6d69, \u5185\u85e4 \u6cf0\u5b8f, \u4e2d\u5cf6 \u5f18\uff0c\u7cd6\u5c3f\u75c5\uff080021-437X\uff0954\u5dfbSuppl.1 PageS-102\uff082011.04\uff09<\/li>\n
        5. \u7d30\u80de\u5185\u30a2\u30f3\u30e2\u30cb\u30a2\u4ee3\u8b1d\u30e2\u30c7\u30eb\u306b\u57fa\u3065\u304f\u7d44\u7e54\u30ec\u30d9\u30eb\u4ee3\u8b1d\u533a\u57df\u5316\u306e\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\uff0c\u5185\u85e4 \u6cf0\u5b8f\uff08\u6176\u5fdc\u7fa9\u587e\u5927\u5b66 \u74b0\u5883\u60c5\u5831\uff09, \u4e2d\u5cf6 \u5f18\uff0c\u65e5\u672c\u751f\u5316\u5b66\u4f1a\u5927\u4f1a\u30d7\u30ed\u30b0\u30e9\u30e0\u30fb\u8b1b\u6f14\u8981\u65e8\u96c682\u56de Page2S17p-1\uff082009.09\uff09<\/li>\n
        6. \u7cd6\u5c3f\u75c5\u30b7\u30df\u30e5\u30ec\u30fc\u30bf\u306b\u3088\u308b\u85ac\u5264\u611f\u53d7\u6027\u4e88\u6e2c\u3000\u30d3\u30b0\u30a2\u30ca\u30a4\u30c9\u85ac\u5264\uff0cWu Peihong, \u6e05\u5bb6 \u8056\u5609, Liu Wei, Cai Yiting, Wang Lihua, Wu Yihua, Yue Jiang, Teng Xiangyu, \u7530\u5cf6 \u6176\u5f66, \u9678 \u5efa\u9280, \u5185\u85e4 \u6cf0\u5b8f, \u4e2d\u5cf6 \u5f18, \u9ad8\u5730 \u6cf0\u6d69\uff0c\u7cd6\u5c3f\u75c5\uff080021-437X\uff0953\u5dfbSuppl.1 PageS-214\uff082010.04\uff09<\/li>\n
        7. \u6c7a\u5b9a\u6728\u3092\u7528\u3044\u305f\u539f\u767a\u6027\u4e73\u764c\u306b\u304a\u3051\u308b\u814b\u7aa9\u30ea\u30f3\u30d1\u7bc0\u8ee2\u79fb\u4e88\u6e2c\u3068\u4e88\u6e2c\u56e0\u5b50\u306e\u63a2\u7d22\uff0c\u9ad8\u7530 \u6b63\u6cf0, \u6749\u672c \u660c\u5f18, \u5185\u85e4 \u6cf0\u5b8f, \u9ed2\u4e95 \u514b\u660c, \u51a8\u7530 \u52dd, \u6238\u4e95 \u96c5\u548c\uff0c\u65e5\u672c\u4e73\u764c\u5b66\u4f1a\u7dcf\u4f1a\u30d7\u30ed\u30b0\u30e9\u30e0\u6284\u9332\u96c617\u56de Page195\uff082009.06\uff09<\/li>\n
        8. \u7cd6\u5c3f\u75c5\u30b7\u30df\u30e5\u30ec\u30fc\u30bf\u306b\u3088\u308b\u85ac\u5264\u52b9\u679c\u306e\u5224\u5b9a\uff0cWu Peihong, \u7530\u5cf6 \u6176\u5f66, Liu Wei, Wang Lihua, Wu Yihua, \u6e05\u5bb6 \u8056\u5609, \u5185\u85e4 \u6cf0\u5b8f, \u4e2d\u5cf6 \u5f18, \u9ad8\u5730 \u6cf0\u6d69\uff0c\u7cd6\u5c3f\u75c5\uff080021-437X\uff0952\u5dfbSuppl.1 PageS-227\uff082009.04\uff09<\/li>\n
        9. \u7cd6\u5c3f\u75c5\u30b7\u30df\u30e5\u30ec\u30fc\u30bf\u306b\u3088\u308b\u30a4\u30f3\u30b9\u30ea\u30f3\u5206\u6ccc\u80fd\u306e\u63a8\u5b9a\u7cbe\u5ea6\u306e\u691c\u8a3c\uff0c\u677e\u4e45 \u5b97\u82f1, \u6e05\u5bb6 \u8056\u5609, \u7530\u5cf6 \u6176\u5f66, \u9ad8\u5730 \u6cf0\u6d69, \u5185\u85e4 \u6cf0\u5b8f, \u5742\u53e3 \u4e00\u5f66, \u51a8\u7530 \u6643\u53f8, \u5c0f\u6749 \u572d\u53f3, \u4e2d\u5cf6 \u5f18, \u67cf\u6728 \u539a\u5178\uff0c\u7cd6\u5c3f\u75c5\uff080021-437X\uff0952\u5dfbSuppl.1 PageS-227\uff082009.04\uff09<\/li>\n
        10. \u7cd6\u5c3f\u75c5\u30b7\u30df\u30e5\u30ec\u30fc\u30bf\u306b\u3088\u308b\u7cd6\u4ee3\u8b1d\u52d5\u614b\u306e\u6570\u7406\u89e3\u6790\uff0c\u6e05\u5bb6 \u8056\u5609, \u6589\u85e4 \u592a\u8a08\u96c4, \u7530\u5cf6 \u6176\u5f66, \u9ad8\u5730 \u6cf0\u6d69, \u5185\u85e4 \u6cf0\u5b8f, \u5742\u53e3 \u4e00\u5f66, \u51a8\u7530 \u6643\u53f8, \u677e\u4e45 \u5b97\u82f1, \u5c0f\u6749 \u572d\u53f3, \u4e2d\u5cf6 \u5f18, \u67cf\u6728 \u539a\u5178\uff0c\u7cd6\u5c3f\u75c5\uff080021-437X\uff0952\u5dfbSuppl.1 PageS-227\uff082009.04\uff09<\/li>\n
        11. \u5acc\u6c17\u6027\u95be\u5024\u304a\u3088\u3073\u6700\u9ad8\u9178\u7d20\u6442\u53d6\u91cf\u3068\u30a4\u30f3\u30b9\u30ea\u30f3\u62b5\u6297\u6027\u306e\u95a2\u4fc2\uff0c\u5c71\u7530 \u609f, \u6728\u4e0b \u8a13\u5149, \u4e2d\u8c37 \u6bd4\u5442\u5fd7, \u5165\u6c5f \u6f64\u4e00\u90ce, \u9ad8\u5730 \u6cf0\u6d69, \u5185\u85e4 \u6cf0\u5b8f, \u4e2d\u5cf6 \u5f18\uff0c\u7cd6\u5c3f\u75c5\uff080021-437X\uff0952\u5dfbSuppl.1 PageS-221\uff082009.04\uff09<\/li>\n
        12. \u7cd6\u5c3f\u75c5\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u7528\u3044\u305f\u8a3a\u7642\u652f\u63f4\u30b7\u30b9\u30c6\u30e0\u306e\u6709\u7528\u6027\u3068\u8ab2\u984c\uff0c\u6728\u6751 \u8087, \u795e\u6d25 \u4ec1, \u83c5\u539f \u6b63\u5f18, \u9678 \u5efa\u9280, \u9ad8\u5730 \u6cf0\u6d69, \u5185\u85e4 \u6cf0\u5b8f, \u4e2d\u5cf6 \u5f18\uff0c\u7cd6\u5c3f\u75c5\uff080021-437X\uff0952\u5dfbSuppl.1 PageS-206\uff082009.04\uff09<\/li>\n
        13. \u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u7528\u3044\u305f\u7cd6\u5c3f\u75c5\u75c5\u614b\u306e\u591a\u6b21\u5143\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u5316\uff0c\u6589\u85e4 \u592a\u8a08\u96c4, \u6e05\u5bb6 \u8056\u5609, \u9ad8\u5730 \u6cf0\u6d69, \u5185\u85e4 \u6cf0\u5b8f, \u4e2d\u5cf6 \u5f18, \u6d45\u91ce \u85ab\uff0c\u7cd6\u5c3f\u75c5\uff080021-437X\uff0950\u5dfbSuppl.1 PageS-334\uff082007.04\uff09<\/li>\n
        14. \u7cd6\u5c3f\u75c5\u75c5\u614b\u30b7\u30df\u30e5\u30ec\u30fc\u30bf\u306b\u3088\u308b\u30a4\u30f3\u30b9\u30ea\u30f3\u62b5\u6297\u6027\u306e\u89e3\u6790\uff0c\u6589\u85e4 \u592a\u8a08\u96c4, \u6e05\u5bb6 \u8056\u5609, \u9ad8\u5730 \u6cf0\u6d69, \u6d45\u91ce \u85ab, \u5927\u539f \u6bc5, \u5185\u85e4 \u6cf0\u5b8f, \u4e2d\u5cf6 \u5f18\uff0c\u7cd6\u5c3f\u75c5\uff080021-437X\uff0949\u5dfbSuppl.1 PageS90\uff082006.04\uff09<\/li>\n
        15. \u7cd6\u5c3f\u75c5\u75c5\u614b\u30b7\u30df\u30e5\u30ec\u30fc\u30bf\u306b\u3088\u308b\u85ac\u5264\u52b9\u679c\u306e\u89e3\u6790\uff0c\u6e05\u5bb6 \u8056\u5609, \u6589\u85e4 \u592a\u8a08\u96c4, \u9ad8\u5730 \u6cf0\u6d69, \u6d45\u91ce \u85ab, \u5185\u85e4 \u6cf0\u5b8f, \u4e2d\u5cf6 \u5f18\uff0c\u7cd6\u5c3f\u75c5\uff080021-437X\uff0949\u5dfbSuppl.1 PageS90\uff082006.04\uff09<\/li>\n
        16. \u5236\u9650\u4fee\u98fe\u907a\u4f1d\u5b50EcoRII\u306b\u3088\u308b\u5206\u96e2\u5f8c\u5bbf\u4e3b\u6bba\u3057\u306b\u30e1\u30c1\u30eb\u5316\u9175\u7d20dcm\u907a\u4f1d\u5b50\u304c\u62b5\u6297\u3059\u308b\uff0c\u5185\u85e4 \u6cf0\u5b8f, \u534a\u7530 \u76f4\u53f2, \u5c0f\u6797 \u4e00\u4e09\uff0c\u751f\u5316\u5b66\uff080037-1017\uff0971\u5dfb8\u53f7 Page1080\uff081999.08\uff09<\/li>\n
        17. \u30b2\u30ce\u30e0\u306f\u306a\u305c\u5909\u308f\u308b\u306e\u304b?\u3000\u75c5\u539f\u4f53\u3068\u3057\u3066\u306e\u5236\u9650\u9175\u7d20\u4fee\u98fe\u9175\u7d20\u907a\u4f1d\u5b50\u304c\u8d77\u3053\u3059\u30b2\u30ce\u30e0\u518d\u7de8\uff0c\u5c0f\u6797 \u4e00\u4e09, \u534a\u7530 \u76f4\u53f2, \u5185\u85e4 \u6cf0\u5b8f\uff0c\u751f\u5316\u5b66\uff080037-1017\uff0971\u5dfb8\u53f7 Page620\uff081999.08\uff09<\/li>\n
        18. \u30b7\u30b9\u30c6\u30e0\u751f\u7269\u5b66\u306b\u3088\u308b\u7cd6\u5c3f\u75c5\u7814\u7a76\u306e\u65b0\u5c55\u958b\u3000\u7cd6\u5c3f\u75c5\u75c5\u614b\u30b7\u30df\u30e5\u30ec\u30fc\u30bf\u3092\u5229\u7528\u3057\u305f\u8a3a\u7642\u652f\u63f4\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u306e\u958b\u767a\u3068\u305d\u306e\u73fe\u72b6\uff0c\u6d45\u91ce \u85ab, \u9ad8\u5730 \u6cf0\u6d69, \u6589\u85e4 \u592a\u8a08\u96c4, \u5cb8 \u548c\u5e0c, \u6e05\u5bb6 \u8056\u5609, \u5185\u85e4 \u6cf0\u5b8f, \u4e2d\u5cf6 \u5f18\uff0c\u7cd6\u5c3f\u75c5\uff080021-437X\uff0948\u5dfbSuppl.2 PageS43\uff082005.04\uff09<\/li>\n
        19. \u30b7\u30b9\u30c6\u30e0\u30d0\u30a4\u30aa\u30ed\u30b8\u30fc\u3092\u75c5\u614b\u4ee3\u8b1d\u5206\u6790\u306b\u6d3b\u7528\u3059\u308b\u305f\u3081\u306e\u5c55\u958b\u3068\u9650\u754c\uff0c\u5185\u85e4 \u6cf0\u5b8f, \u5927\u91ce \u6d69\uff0c\u7cd6\u5c3f\u75c5\uff080021-437X\uff0948\u5dfbSuppl.2 PageS41\uff082005.04\uff09<\/li>\n
        20. \u7d30\u80de\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u306b\u3088\u308b\u533b\u5b66\u30fb\u751f\u7269\u5b66\u7684\u6d1e\u5bdf\uff0c\u5185\u85e4 \u6cf0\u5b8f\uff0cDrug Delivery System\uff080913-5006\uff0919\u5dfb3\u53f7 Page246\uff082004.05\uff09<\/li>\n
        21. E-Cell\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u306e\u6311\u6226\u3000\u7d30\u80de\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u306b\u3088\u308b\u75c5\u614b\u89e3\u6790\u306e\u8a66\u307f\uff0c\u5185\u85e4 \u6cf0\u5b8f\uff0c\u74b0\u5883\u3068\u5065\u5eb7\uff081880-4055\uff0917\u5dfb2\u53f7 Page78-86\uff082004.04\uff09<\/li>\n
        22. \u30d0\u30a4\u30aa\u30a4\u30f3\u30d5\u30a9\u30de\u30c6\u30a3\u30c3\u30af\u30b9\u306b\u3088\u308b\u7cd6\u5c3f\u75c5\u75c5\u614b\u89e3\u660e\uff08\u7b2c4\u5831\uff09\u3000E-cell\u30d9\u30fc\u30b9\u306e\u4eba\u5de5\u77e5\u80fd\u578b\u7cd6\u5c3f\u75c5\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u30b7\u30b9\u30c6\u30e0\u306e\u958b\u767a\uff0c\u4e2d\u5cf6 \u5f18, \u5185\u85e4 \u6cf0\u5b8f, \u51a8\u7530 \u52dd, \u9ad8\u5730 \u6cf0\u6d69, \u6589\u85e4 \u592a\u8a08\u96c4, \u6d45\u91ce \u85ab\uff0c\u7cd6\u5c3f\u75c5\uff080021-437X\uff0947\u5dfbSuppl.1 PageS142\uff082004.04\uff09<\/li>\n
        23. E-Cell\u306b\u3088\u308b\u7cd6\u5c3f\u75c5\u75c5\u614b\u30e2\u30c7\u30eb\u306e\u69cb\u7bc9\u3000\u30dd\u30b9\u30c8\u30b2\u30ce\u30e0\u5275\u85ac\u30c4\u30fc\u30eb\uff0c\u4e2d\u5cf6 \u5f18, \u5185\u85e4 \u6cf0\u5b8f, \u5927\u91ce \u6d69, \u51a8\u7530 \u52dd\uff0c\u65e5\u672c\u81e8\u5e8a\u5206\u5b50\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u30d7\u30ed\u30b0\u30e9\u30e0\u30fb\u6284\u9332\u96c639\u56de Page51\uff082002.03\uff09<\/li>\n
        24. \u30d0\u30a4\u30aa\u30a4\u30f3\u30d5\u30a9\u30de\u30c6\u30a3\u30c3\u30af\u30b9\u306b\u3088\u308b\u7cd6\u5c3f\u75c5\u75c5\u614b\u89e3\u660e\uff08\u7b2c3\u5831\uff09\u3000\u5b9f\u7528\u5316\u5927\u898f\u6a21\u30e2\u30c7\u30ea\u30f3\u30b0\u3092\u76ee\u6307\u3057\u305f\u81d3\u5668\u30e2\u30c7\u30eb\u306e\u69cb\u7bc9\uff0c\u4e2d\u5cf6 \u5f18, \u5185\u85e4 \u6cf0\u5b8f, \u5927\u91ce \u6d69, \u51a8\u7530 \u52dd\uff0c\u7cd6\u5c3f\u75c5\uff080021-437X\uff0946\u5dfbSuppl.1 PageS195\uff082003.04\uff09<\/li>\n
        25. E-Cell\u306b\u3088\u308b\u7cd6\u5c3f\u75c5\u75c5\u614b\u30e2\u30c7\u30eb\u306e\u69cb\u7bc9:\u30dd\u30b9\u30c8\u30b2\u30ce\u30e0\u5275\u85ac\u30c4\u30fc\u30eb\uff0c\u4e2d\u5cf6 \u5f18, \u5185\u85e4 \u6cf0\u5b8f, \u5927\u91ce \u6d69, \u51a8\u7530 \u52dd\uff0c\u65e5\u672c\u81e8\u5e8a\u5206\u5b50\u533b\u5b66\u4f1a\u8a18\u933239\u5dfb Page59\uff082002.09\uff09<\/li>\n
        26. \u30d0\u30a4\u30aa\u30a4\u30f3\u30d5\u30a9\u30de\u30c6\u30a3\u30c3\u30af\u30b9\u306b\u3088\u308b\u7cd6\u5c3f\u75c5\u75c5\u614b\u89e3\u660e\uff08\u7b2c2\u5831\uff09\u3000E-cell\u306b\u3088\u308b\u81b5\u30d9\u30fc\u30bf\u7d30\u80de\u30fb\u809d\u306e\u4ee3\u8b1d\u3068\u6a5f\u80fd\u306e\u30e2\u30c7\u30eb\u5316\uff0c\u4e2d\u5cf6 \u5f18, \u5185\u85e4 \u6cf0\u5b8f, \u5927\u91ce \u6d69, \u51a8\u7530 \u52dd\uff0c\u7cd6\u5c3f\u75c5\uff080021-437X\uff0945\u5dfbSuppl.2 PageS110\uff082002.04\uff09<\/li>\n
        27. \u30d0\u30a4\u30aa\u30a4\u30f3\u30d5\u30a9\u30de\u30c6\u30a3\u30c3\u30af\u30b9\u306b\u3088\u308b\u7cd6\u5c3f\u75c5\u75c5\u614b\u89e3\u660e\u306e\u8a66\u307f\uff08\u7b2c\u4e00\u5831\uff09\u3000\u5168\u7d30\u80de\u30b7\u30df\u30e5\u30ec\u30fc\u30bf\u30fc\u306b\u3088\u308b\u81b5\u30d9\u30fc\u30bf\u7d30\u80de\u89e3\u7cd6\u7cfb\u306e\u30e2\u30c7\u30eb\u5316\uff0c\u4e2d\u5cf6 \u5f18, \u5185\u85e4 \u6cf0\u5b8f, \u51a8\u7530 \u52dd\uff0c\u7cd6\u5c3f\u75c5\uff080021-437X\uff0944\u5dfbSuppl.1 PageS184\uff082001.03\uff09<\/li>\n
        28. E-CELL\u3092\u7528\u3044\u305f\u30b3\u30f3\u30d1\u30fc\u30c8\u30e1\u30f3\u30c8\u30e2\u30c7\u30eb\u306b\u3088\u308b\u7cd6\u5c3f\u75c5\u75c5\u614b\u306e\u518d\u73fe\uff0c\u4e2d\u5cf6 \u5f18, \u5185\u85e4 \u6cf0\u5b8f, \u5927\u91ce \u6d69, \u51a8\u7530 \u52dd\uff0c\u65e5\u672c\u81e8\u5e8a\u5206\u5b50\u533b\u5b66\u4f1a\u8a18\u933238\u5dfb Page39\uff082002.02\uff09<\/li>\n
        29. E-Cell\u3092\u7528\u3044\u305f\u30b3\u30f3\u30d1\u30fc\u30c8\u30e1\u30f3\u30c8\u30e2\u30c7\u30eb\u306b\u3088\u308b\u7cd6\u5c3f\u75c5\u75c5\u614b\u306e\u767a\u73fe\uff0c\u4e2d\u5cf6 \u5f18, \u5185\u85e4 \u6cf0\u5b8f, \u51a8\u7530 \u52dd\uff0c\u65e5\u672c\u81e8\u5e8a\u5206\u5b50\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u30d7\u30ed\u30b0\u30e9\u30e0\u30fb\u6284\u9332\u96c638\u56de Page45\uff082001.08\uff09<\/li>\n
        30. \u5168\u7d30\u80de\u30b7\u30df\u30e5\u30ec\u30fc\u30bf\u30fc E-CELL \u306b\u3088\u308b\u81b5\u03b2\u7d30\u80de\u89e3\u7cd6\u7cfb\u306e\u30e2\u30c7\u30ea\u30f3\u30b0\uff0c\u5185\u85e4 \u6cf0\u5b8f, \u4e2d\u5cf6 \u5f18, \u51a8\u7530 \u52dd\uff0c\u7b2c23\u56de\u65e5\u672c\u5206\u5b50\u751f\u7269\u5b66\u4f1a\u5e74\u4f1a\uff0c\u795e\u6238\uff0c2000.12.16<\/li>\n
        31. \u5236\u9650\u9175\u7d20\u4fee\u98fe\u9175\u7d20\u7cfb\u9593\u306e\u5bbf\u4e3b\u5185\u7af6\u4e89\u3068\u30b7\u30fc\u30af\u30a8\u30f3\u30b9\u8a8d\u8b58\u306e\u9032\u5316\uff0c\u77e5\u5ff5 \u79cb\u4eba, \u5185\u85e4 \u6cf0\u5b8f, \u534a\u7530 \u76f4\u53f2, \u5c0f\u6797 \u4e00\u4e09\uff0c\u751f\u5316\u5b66\uff080037-1017\uff0972\u5dfb8\u53f7 Page833\uff082000.08\uff09<\/li>\n
        32. \u5229\u5df1\u7684\u306a\u5236\u9650\u9175\u7d20\u4fee\u98fe\u9175\u7d20\u907a\u4f1d\u5b50\u3068\u30aa\u30fc\u30d5\u30a1\u30f3\u4fee\u98fe\u9175\u7d20\u907a\u4f1d\u5b50\u306e\u7d30\u83cc\u30b2\u30ce\u30e0\u306e\u5869\u57fa\u914d\u5217\u3092\u3081\u3050\u308b\u7af6\u4e89\uff0c\u77e5\u5ff5 \u79cb\u4eba, \u5185\u85e4 \u6cf0\u5b8f, \u534a\u7530 \u76f4\u53f2, \u5c0f\u6797 \u4e00\u4e09\uff0c\u65e5\u672c\u7d30\u83cc\u5b66\u96d1\u8a8c\uff080021-4930\uff0955\u5dfb2\u53f7 Page295\uff082000.04\uff09<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

          Publications \u201cSurvival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multi center retrospective observational study (JBCRG-C03 study).\u201d Takada M, Ishiguro H, Nagai S, Ohtani S, Kawabata H, Yanagita Y, Hozumi Y, Shimizu C, Takao S, Sato N, Kosaka Y, Sagara Y, Iwata H, Ohno S, Kuroi K, Masuda N, Yamashiro H, Sugimoto M, Kondo M, Naito Y, Sasano H, Inamoto T, Morita S, Toi M. Breast Cancer Res Treat 2014 Mar 30. [Epub ahead of print] Journal Site “Contribution of quantitative changes in individual ionic current systems to the embryonic development of ventricular myocytes: a simulation study.” Okubo C, Sano HI, Naito Y, Tomita M. … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":3,"comment_status":"closed","ping_status":"open","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/singularities.sfc.keio.ac.jp\/wp\/index.php?rest_route=\/wp\/v2\/pages\/588"}],"collection":[{"href":"https:\/\/singularities.sfc.keio.ac.jp\/wp\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/singularities.sfc.keio.ac.jp\/wp\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/singularities.sfc.keio.ac.jp\/wp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/singularities.sfc.keio.ac.jp\/wp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=588"}],"version-history":[{"count":37,"href":"https:\/\/singularities.sfc.keio.ac.jp\/wp\/index.php?rest_route=\/wp\/v2\/pages\/588\/revisions"}],"predecessor-version":[{"id":773,"href":"https:\/\/singularities.sfc.keio.ac.jp\/wp\/index.php?rest_route=\/wp\/v2\/pages\/588\/revisions\/773"}],"wp:attachment":[{"href":"https:\/\/singularities.sfc.keio.ac.jp\/wp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=588"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}